{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:36:31Z","timestamp":1788456991289,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jceh.2023.101342","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T16:27:07Z","timestamp":1703608027000},"page":"101342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of Yttrium-90 Transarterial Radioembolisation in Advanced Hepatocellular Carcinoma: An Experience With Hybrid Angio-Computed Tomography and Glass Microspheres"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3369-6409","authenticated-orcid":false,"given":"Abhiman","family":"Baloji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-2185","authenticated-orcid":false,"given":"Sreedhara","family":"Chaluvashetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3795-8795","authenticated-orcid":false,"given":"Harish","family":"Bhujade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karamvir","family":"Chandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-2664","authenticated-orcid":false,"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujjwal","family":"Gorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-0361","authenticated-orcid":false,"given":"Ashwani","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-4416","authenticated-orcid":false,"given":"Anish","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baljinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwant R.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manavjit S.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2023.101342_bib1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.101342_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jceh.2014.05.013","article-title":"Epidemiology of hepatocellular carcinoma in India","volume":"4","author":"Acharya","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2023.101342_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jhep.2015.10.029","article-title":"Prognosis of hepatocellular carcinoma: assessment of eleven staging systems","volume":"64","author":"Liu","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.101342_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2023.101342_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0168-8278(02)00432-4","article-title":"Hepatocellular carcinoma: present status and future prospects","volume":"38","author":"Llovet","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.101342_bib6","first-page":"348","article-title":"Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions","volume":"32","author":"Bolondi","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2023.101342_bib7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3748\/wjg.v13.i3.414","article-title":"Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma","volume":"13","author":"Uka","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.101342_bib8","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/hep.24812","article-title":"Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients","volume":"55","author":"Senthilnathan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.101342_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jhep.2011.07.012","article-title":"Radioembolization for hepatocellular carcinoma","volume":"56","author":"Sangro","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.101342_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.101342_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.101342_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2008-1052306","article-title":"Radioembolization of yttrium-90 microspheres for hepatic malignancy","volume":"25","author":"Murthy","year":"2008","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.101342_bib14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"Hilgard","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.101342_bib15","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.101342_bib16","series-title":"Handbook of Radioembolization","first-page":"53","article-title":"Treatment planning part I: vascular considerations associated with safety and efficacy in radioembolization","author":"Bradford","year":"2017"},{"key":"10.1016\/j.jceh.2023.101342_bib17","series-title":"Handbook of Radioembolization","first-page":"65","article-title":"Treatment planning part II: procedure simulation and prognostication","author":"Srinivas","year":"2017"},{"key":"10.1016\/j.jceh.2023.101342_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/JHC.S248314","article-title":"Survival outcomes for Yttrium-90 transarterial radioembolization with and without sorafenib for unresectable hepatocellular carcinoma patients","volume":"7","author":"Teyateeti","year":"2020","journal-title":"J\u00a0Hepatocell Carcinoma"},{"key":"10.1016\/j.jceh.2023.101342_bib19","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 Radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.101342_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2023.101342_bib21","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2023.101342_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00270-009-9592-9","article-title":"Biocompatibility, inflammatory response, and recanalization characteristics of nonradioactive resin microspheres: histological findings","volume":"32","author":"Bilbao","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.semnuclmed.2016.01.008","article-title":"Intra-Arterial radionuclide therapies for liver tumours","volume":"46","author":"Bozkurt","year":"2016","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jceh.2023.101342_bib24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.26191","article-title":"Prognostic factors and prevention of radioembolization-induced liver disease","volume":"57","author":"Gil-Alzugaray","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.101342_bib25","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1038\/s41598-021-82887-w","article-title":"Diagnostic and prognostic value of 99mTc-MAA SPECT\/CT for treatment planning of 90Y-resin microsphere radioembolization for hepatocellular carcinoma: comparison with planar image","volume":"11","author":"Son","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2023.101342_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/2191-219X-3-56","article-title":"Post-radioembolization yttrium-90 PET\/CT \u2013 part 1: diagnostic reporting","volume":"3","author":"Kao","year":"2013","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jceh.2023.101342_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/RLU.0b013e31821c9a11","article-title":"Yttrium-90 time-of-flight PET\/CT is superior to Bremsstrahlung SPECT\/CT for post radioembolization imaging of microsphere biodistribution","volume":"3","author":"Kao","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jceh.2023.101342_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-0040-1720954","article-title":"Yttrium-90 radioembolization dosimetry: what trainees need to know","volume":"37","author":"Villalobos","year":"2020","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-022-05956-w","article-title":"Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group","volume":"50","author":"Salem","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.jceh.2023.101342_bib30","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00259-013-2395-x","article-title":"Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept","volume":"40","author":"Garin","year":"2013","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.jceh.2023.101342_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2967\/jnumed.114.145177","article-title":"Personalized dosimetry and intensification concept with 90Y-loaded glass microsphere radioembolization induce prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis","volume":"56","author":"Garin","year":"2015","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jceh.2023.101342_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"DOSISPHERE-01 Study Group. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.101342_bib33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/JHC.S318865","article-title":"A\u00a0prospective phase II study of safety and efficacy of sorafenib followed by (90)Y glass microspheres for patients with advanced or metastatic hepatocellular carcinoma","volume":"8","author":"Kaseb","year":"2021","journal-title":"J\u00a0Hepatocell Carcinoma"},{"key":"10.1016\/j.jceh.2023.101342_bib34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cncr.24884","article-title":"Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study","volume":"116","author":"Carr","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2023.101342_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.101342_bib36","doi-asserted-by":"crossref","first-page":"101269","DOI":"10.1016\/j.jceh.2023.08.005","article-title":"2023 update of Indian national association for study of the liver consensus on management of intermediate and advanced hepatocellular carcinoma: the Puri III recommendations","volume":"14","author":"Kumar","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2023.101342_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216935","article-title":"Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: the impact\u00a0of portal vein thrombosis on survival","volume":"14","author":"Somma","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2023.101342_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/rg.281065721","article-title":"Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay","volume":"28","author":"Atassi","year":"2008","journal-title":"Radiographics"},{"key":"10.1016\/j.jceh.2023.101342_bib39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.5009\/gnl19197","article-title":"The modified response evaluation criteria in solid tumours (RECIST) yield a more accurate prognoses than the RECIST 1.1 in hepatocellular carcinoma treated with transarterial radioembolization","volume":"14","author":"Lee","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2023.101342_bib40","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijrobp.2017.05.049","article-title":"Transarterial radioembolization versus concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma: a propensity score matching analysis","volume":"99","author":"Song","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.jceh.2023.101342_bib41","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140126","article-title":"Current role of hybrid CT\/angiography system compared with C-arm cone beam CT for interventional oncology","volume":"87","author":"Tanaka","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib42","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1007\/s00261-020-02914-8","article-title":"Hybrid angiography-CT for transarterial radioembolization: a pictorial essay","volume":"46","author":"Lionberg","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jceh.2023.101342_bib43","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00270-019-02269-8","article-title":"Radiation exposure during transarterial chemoembolization: Angio-CT versus cone-beam CT","volume":"42","author":"Piron","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib44","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2214\/AJR.08.1368","article-title":"Impact of a unified CT angiography system on outcome of patients with hepatocellular carcinoma","volume":"192","author":"Toyoda","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jceh.2023.101342_bib45","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00270-019-02362-y","article-title":"Catheter-directed computed tomography hepatic angiography for Yttrium-90 selective internal radiotherapy of hepatocellular carcinoma reduces prophylactic embolization of extrahepatic vessels","volume":"43","author":"Goh","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jvir.2020.10.021","article-title":"Radiation dose during transarterial radioembolization: a dosimetric comparison of cone-beam CT and Angio-CT technologies","volume":"32","author":"Marshall","year":"2021","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.acra.2018.04.007","article-title":"Angio-CT-guided transarterial chemoembolization immediately in combination with radiofrequency ablation for large hepatocellular carcinoma","volume":"26","author":"Yuan","year":"2019","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib48","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY Study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.101342_bib49","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jceh.2023.101342_bib50","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma","volume":"36","author":"Chow","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2023.101342_bib51","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/COC.0b013e3182a78dba","article-title":"Radioembolization with yttrium-90 resin microspheres in hepatocellular carcinoma: a multicenter prospective study","volume":"38","author":"Kim","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jceh.2023.101342_bib52","series-title":"30th Annual Scientific Meeting of Indian National Association for Study of the Liver; 2022 Aug 4-7; New Delhi, India","first-page":"56","author":"Baloji","year":"2022"},{"key":"10.1016\/j.jceh.2023.101342_bib53","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.101342_bib54","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12876-022-02396-6","article-title":"Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review","volume":"22","author":"Alonso","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2023.101342_bib55","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jvir.2014.04.014","article-title":"Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma","volume":"25","author":"Rostambeigi","year":"2014","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejso.2020.08.027","article-title":"The cost-effectiveness of TheraSphere in patients with hepatocellular carcinoma who are eligible for transarterial embolization","volume":"47","author":"Manas","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jceh.2023.101342_bib57","first-page":"279","article-title":"Economic evaluation of glass Yttrium-90 microspheres versus sorafenib for the treatment of advanced hepatocellular carcinoma: cost effectiveness analysis in the United Kingdom","volume":"38","author":"Chaplin","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2023.101342_bib58","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jhep.2019.08.006","article-title":"Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma","volume":"71","author":"Ricke","year":"2019","journal-title":"J\u00a0Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323008757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323008757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T21:13:06Z","timestamp":1715721186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688323008757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0973688323008757"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2023.101342","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Yttrium-90 Transarterial Radioembolisation in Advanced Hepatocellular Carcinoma: An Experience With Hybrid Angio-Computed Tomography and Glass Microspheres","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2023.101342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101342"}}